Scholarlink

Background <p>Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and poses a considerable public health challenge; concurrently, Clostridioides difficile infection (CDI) represents a significant hospital-acquired infection, with a rising incidence observed among cancer patients.</p> Aim <p>To examine the relationship between CDI and CRC, it will address the risk factors associated with CDI in patients with CRC, clinical outcomes, recent findings regarding the influence of CDI on CRC, and the current strategies for management.</p> Results <p>Risk factors including gut microbiota dysbiosis, surgical interventions, chemotherapy, immunotherapy, prolonged hospitalization, and antibiotic exposure elevate susceptibility to CDI in CRC patients. Additionally, CDI correlates with more complex treatment regimens and longer hospital stays in this demographic. Furthermore, recent studies indicate that the incidence of CDI may increase the risk of CRC development.</p> Conclusion <p>The prevention, diagnosis, and treatment of CDI in CRC patients are critical for enhancing outcomes. A comprehensive understanding of the bidirectional relationship between CDI and CRC can guide the development of management strategies for this important clinical issue.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

C. difficile Infection in Colorectal Cancer: Risk Determinants, Outcomes, and Evolving Management Approaches

  • 期刊论文

  • 发表日期：

    2025年10月14日

查看全文
  • Mustafa Khalid AbdulJabbar,
  • Susan Saab Manfi Al-Rawi,
  • Bilal Khaleel Midhin,
  • Roghayeh Mohammadzadeh,
  • Raad N. Hasan,
  • Mobina Kouhzad,
  • Nasrin Alanchari,
  • Erta Rajabi

摘要

Background

Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and poses a considerable public health challenge; concurrently, Clostridioides difficile infection (CDI) represents a significant hospital-acquired infection, with a rising incidence observed among cancer patients.

Aim

To examine the relationship between CDI and CRC, it will address the risk factors associated with CDI in patients with CRC, clinical outcomes, recent findings regarding the influence of CDI on CRC, and the current strategies for management.

Results

Risk factors including gut microbiota dysbiosis, surgical interventions, chemotherapy, immunotherapy, prolonged hospitalization, and antibiotic exposure elevate susceptibility to CDI in CRC patients. Additionally, CDI correlates with more complex treatment regimens and longer hospital stays in this demographic. Furthermore, recent studies indicate that the incidence of CDI may increase the risk of CRC development.

Conclusion

The prevention, diagnosis, and treatment of CDI in CRC patients are critical for enhancing outcomes. A comprehensive understanding of the bidirectional relationship between CDI and CRC can guide the development of management strategies for this important clinical issue.